Author = Yekta Rameshi
Aducanumab: A Novel Drug for Alzheimer's Disease; Future Challenges in Treatment

Volume 2, Issue 1, September 2022, Pages 1-3

Reza Bidaki; Yekta Rameshi; Farahnaz Hoseinzade; Fatemeh Saghafi


Acute Trismus Follow Benzodiazepine Discontinuation in a Rural Addicted Patient

Volume 2, Issue 1, September 2022, Pages 11-13

Mahsa Motamed; Yekta Rameshi; Fatemeh Saghafi; Sina Taherzadeh Borujeni; Reza Bidaki


Comparing the frequency tramadol abuse in seizure and non-seizure complaint patients referred to neurology emergency department of a university affiliated hospital

Volume 1, Issue 2, December 2021, Pages 58-64

Reza Bidaki; Adeleh Sahebnasagh; Yekta Rameshi; Atena Khaleghi; Amir Moghadam Ahmadi; Golnar Moenian Bagheri; Vahid Ramezani; Fatemeh Saghafi


Ketamine as a novel treatment protocol for treatment-resistant major depressive disorder

Volume 1, Issue 2, December 2021, Pages 89-97

Atena Fallahtafti; Seyed Mojtaba Yasini; Fatemeh Saghafi; Reza Bidaki; Hossein Jafari; Mahmoud Vakili; Yekta Rameshi